Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas

References

1. Allday M. J., Kundu D., Finerty S., Griffin B. E. 1990; CpG methylation of viral DNA in EBV-associated tumours. International Journal of Cancer 45:1125–1130
   [Google Scholar]
2. Altiok E., Minarovits J., Hu L. F., Contreras-Brodin B., Klein G., Ernberg I. 1992; Host-cell-phenotype-dependent control of BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens, 2–6. Proceedings of the National Academy of Sciences U.S.A.: 89905–909
   [Google Scholar]
3. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Séguin C., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature; London: 310207–211
   [Google Scholar]
4. Bodescot M., Perricaudet M., Farrell P. 1987; A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. Journal of Virology 61:3424–3430
   [Google Scholar]
5. Chomczynski P., Sacchi N. 1987; Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162:156–159
   [Google Scholar]
6. Ernberg I., Falk K., Minarovits J., Busson P., Tursz T., Masucci M. G., Klein G. 1989; The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. Journal of General Virology 70:2989–3002
   [Google Scholar]
7. Fåhraeus R., Hu L. F., Ernberg I., Finke J., Rowe M., Falk K., Klein G., Nilsson E., Yadav M., Busson M., Tursz T., Kallin B. 1988; Expression of Epstein-Barr virus encoded proteins in nasopharyngeal carcinoma. International Journal of Cancer 42:329–338
   [Google Scholar]
8. Fåhraeus R., Jansson A., Ricksten A., Sjoblom A., Rymo L. 1990; Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proceedings of the National Academy of Sciences U.S.A.: 877390–7394
   [Google Scholar]
9. Gaulard P., Henni T., Marolleau J.-P., Haioun C, Voisin M.-C., Divine M., Goossens M., Farcet J.-P., Reyes F. 1988; Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder. Cancer 62:705–710
   [Google Scholar]
10. Gross D. S., Garrard W. T. 1988; Nuclease hypersensitive sites in chromatin. Annual Review of Biochemistry 57:159–197
    [Google Scholar]
11. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. 1990; Epstein-Barr virus in patients with lethal midline granuloma. Lancet 335:128–130
    [Google Scholar]
12. Hu L. F., Minarovits J., Contreras-Salazar B., Rymo L., Falk K., Klein G., Ernberg I. 1991; Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5′ flanking region. Journal of Virology 65:1558–1567
    [Google Scholar]
13. Katz B. Z., Raab-Traub N., Miller G. 1989; Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. Journal of Infectious Diseases 160:589–598
    [Google Scholar]
14. Kikuta H., Taguchi Y., Tomizawa K., Kojima K., Kawamura N., Ishizaka A., Sakiyama Y., Matsumoto S., Imai S., Kinoshita T., Koizumi S., Osato T., Kobayashi L, Hirai K. 1988; Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature; London: 333455–157
    [Google Scholar]
15. Lipford E. H., Margolick J. B., Longo D. L., Fauci A. S., Jaffe E. S. 1988; Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 12:1674–1681
    [Google Scholar]
16. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
17. Minarovits J., Minarovits-Kormuta S., Ehlin-Henriksson B., Falk K., Klein G., Ernberg 1. 1991; Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. Journal of General Virology 12:1591–1599
    [Google Scholar]
18. Minarovits J., Hu L.-F., Marcsek Z., Minarovits-Kormuta S., Klein G., Ernberg 1. 1992; RNA polymerase Ill-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types. Journal of General Virology 73:1687–1692
    [Google Scholar]
19. Mori M., Kurozumi H., Akagi K., Tanaka Y., Imai S., Osato T. 1992; Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis. New England Journal of Medicine 327:58
    [Google Scholar]
20. Ott G., Ott M. M., Feller A. C., Seidl S., Muller-Hermelink H. K. 1992; Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. International Journal of Cancer 51:562–567
    [Google Scholar]
21. Raab-Traub N., Flynn K. 1986; The structure of the termini of the Epstein-Barr virus as a marker of clonal cell proliferation. Cell 47:883–889
    [Google Scholar]
22. Ricksten A., Olsson A., Andersson T., Rymo L. 1988; The 5′ flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type-specific cis-acting regulatory element that activates transcription in transfected B-cells. Nucleic Acids Research 16:8391–8409
    [Google Scholar]
23. Rowe M.Rowe, Gregory C. D., Young L. S., Farrell P. J., Rupani H., Rickinson A. B. 1987; Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt’s lymphoma cells. EMBO Journal 6:2743–2751
    [Google Scholar]
24. Sample J., Hummel M., Braun D., Birkenbach M., Kieff E. 1986; Nucleotide sequences of messenger RNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proceedings of the National Academe of Sciences U.S.A.: 835096–5100
    [Google Scholar]
25. Sample J., Brooks L., Sample C., Young L., Gregory C., Rickinson A., Kieff E. 1991; Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proceedings oj the National Academy of Sciences U.S.A.: 886343–6347
    [Google Scholar]
26. Schaefer B., Woisetschlaeger M., Strominger J., Speck S. 1991; Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proceedings of the National Academy of Sciences U.S.A.: 886550–6554
    [Google Scholar]
27. Smith P. R., Griffin B. E. 1992; Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. Journal of Virology 66:706–714
    [Google Scholar]
28. Staal S. P., Ambinder R., Beschorner W. E., Hayward G. S., Mann R. 1989; A survey of Epstein-Barr virus DNA in lymphoid tissue: frequent detection in Hodgkin’s disease. American Journal of Clinical Pathology 91:1–5
    [Google Scholar]
29. Waalwijk C., Flavell R. A. 1978; Msp I, an isoschizomer of Hpa II which cleaves both unmethylated and methylated Hpa II sites. Nucleic Acids Research 5:3231–3236
    [Google Scholar]
30. Waldman T. A., Davis M. M., Bongiovanni K. F., Korsmeyer S. J. 1985; Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. New England Journal of Medicine 313:776–783
    [Google Scholar]
31. Weiss L. M., Strickler J. G., Warnke R. A., Purtilo D. T., Sklar J. 1987; Epstein-Barr virus DNA in tissues of Hodgkin’s disease. American Journal of Pathology 129:86–91
    [Google Scholar]
32. Woisetschlaeger M., Strominger J., Speck S. 1989; Mutually exclusive usage of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proceedings of the National Academy of Sciences U.S.A.: 866498–6502
    [Google Scholar]
33. Woisetschlaeger M., Yandava C., Furmansky L., Strominger J., Speck S. 1990; Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proceedings of the National Academy of Sciences U.S.A.: 871725–1729
    [Google Scholar]
34. Yates J., Warren N., Reisman D., Sugden B. 1984; A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proceedings of the National Academy of Sciences U.S.A.: 813806–3810
    [Google Scholar]
35. Yoneda N., Tatsumi E., Kawanishi M., Teshigawara K., Masuda S., Yamamura Y., Inui A., Yoshino G., Oimomi M., Baba S., Yamaguchi N. 1990; Detection of Epstein-Barr virus genome in benign polyclonal proliferative T cells of a young male patient. Blood 76:172–177
    [Google Scholar]